>=1 prior line of therapy, Relapsed Refractory Multiple Myeloma (RRMM), Granulocyte Colony-Stimulating Factor+Placebo (G-CSF+Placebo), Phase 3, Granulocyte Colony-Stimulating Factor+Plerixafor (G-CSF+Plerixafor), CXCR4 Chemokine Receptor Antagonist
### Instruction:
Identify the study with the following condition. 
### Input:
>=1 prior line of therapy, Relapsed Refractory Multiple Myeloma (RRMM), Granulocyte Colony-Stimulating Factor+Placebo (G-CSF+Placebo), Phase 3, Granulocyte Colony-Stimulating Factor+Plerixafor (G-CSF+Plerixafor), CXCR4 Chemokine Receptor Antagonist 
### Output:
Popular Name is AMD3100-3102, Study ID is NCT00103662